Tag: bloom43

All

BLOOM43 Wearable Device Debuts in U.S. to Reduce Breast Surgery Complications

Plexāā has launched its BLOOM43 platform in the U.S., a wearable and app designed to improve surgical outcomes for breast surgery patients through preconditioning.

All

Sorry, No Posts Found

All

FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA

The agency has accepted the resubmission seeking approval of the neuromodulator for the temporary improvement of moderate-to-severe glabellar lines and crow’s feet in adults.

HHS Leaders Back Plastic Surgeons’ Opposition to Gender-Related Surgery for Minors
Recent Antibiotic Use Raises Infection Risk in Tissue Expander–Based Breast Reconstruction
Survey Reveals Knowledge Gap on Menopause-Related Skin Changes

Tag: bloom43

All

BLOOM43 Wearable Device Debuts in U.S. to Reduce Breast Surgery Complications

All

Sorry, No Posts Found

All

FDA Accepts Galderma’s BLA Resubmission for RelabotulinumtoxinA

HHS Leaders Back Plastic Surgeons’ Opposition to Gender-Related Surgery for Minors

Recent Antibiotic Use Raises Infection Risk in Tissue Expander–Based Breast Reconstruction

Survey Reveals Knowledge Gap on Menopause-Related Skin Changes

Sorry, No Posts Found

Plastic Surgery Practice

Our Parent Company

Key Resources

Helpful Links